Found: 100
Select item for more details and to access through your institution.
Contextualized analysis of a needs assessment using the Theoretical Domains Framework: a case example in endocrinology.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Effects of physiologic growth hormone therapy on bone density and body composition in patients...
- Published in:
- Annals of Internal Medicine, 1996, v. 125, n. 11, p. 883, doi. 10.7326/0003-4819-125-11-199612010-00003
- By:
- Publication type:
- Article
Treatment of prolactin-secreting pituitary macroadenomas with the long-acting non-ergot dopamine agonist CV 205-502.
- Published in:
- 1990
- By:
- Publication type:
- journal article
Prolactinomas, Cushing's disease and acromegaly: debating the role of medical therapy of secretory pituitary adenomas.
- Published in:
- BMC Endocrine Disorders, 2010, v. 10, p. 10, doi. 10.1186/1472-6823-10-10
- By:
- Publication type:
- Article
Weekly somapacitan had no adverse effects on glucose metabolism in adults with growth hormone deficiency.
- Published in:
- Pituitary, 2023, v. 26, n. 1, p. 57, doi. 10.1007/s11102-022-01283-3
- By:
- Publication type:
- Article
Long-term efficacy and safety of osilodrostat in Cushing's disease: final results from a Phase II study with an optional extension phase (LINC 2).
- Published in:
- Pituitary, 2022, v. 25, n. 6, p. 959, doi. 10.1007/s11102-022-01280-6
- By:
- Publication type:
- Article
Treatment of Cushing's syndrome with osilodrostat: practical applications of recent studies with case examples.
- Published in:
- Pituitary, 2022, v. 25, n. 6, p. 795, doi. 10.1007/s11102-022-01268-2
- By:
- Publication type:
- Article
Pregnancy outcomes in women receiving growth hormone replacement therapy enrolled in the NordiNet® International Outcome Study (IOS) and the American Norditropin® Studies: Web-Enabled Research (ANSWER) Program.
- Published in:
- Pituitary, 2021, v. 24, n. 4, p. 611, doi. 10.1007/s11102-021-01138-3
- By:
- Publication type:
- Article
Correction to: Levoketoconazole improves clinical signs and symptoms and patient-reported outcomes in patients with Cushing's syndrome.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Levoketoconazole improves clinical signs and symptoms and patient-reported outcomes in patients with Cushing's syndrome.
- Published in:
- Pituitary, 2021, v. 24, n. 1, p. 104, doi. 10.1007/s11102-020-01103-6
- By:
- Publication type:
- Article
A Pituitary Society update to acromegaly management guidelines.
- Published in:
- Pituitary, 2021, v. 24, n. 1, p. 1, doi. 10.1007/s11102-020-01091-7
- By:
- Publication type:
- Article
Surgical debulking of pituitary adenomas improves responsiveness to octreotide lar in the treatment of acromegaly.
- Published in:
- Pituitary, 2017, v. 20, n. 6, p. 668, doi. 10.1007/s11102-017-0832-8
- By:
- Publication type:
- Article
Follow-up intervals in patients with Cushing's disease: recommendations from a panel of experienced pituitary clinicians.
- Published in:
- Pituitary, 2017, v. 20, n. 4, p. 422, doi. 10.1007/s11102-017-0801-2
- By:
- Publication type:
- Article
Pegvisomant: a growth hormone receptor antagonist used in the treatment of acromegaly.
- Published in:
- Pituitary, 2017, v. 20, n. 1, p. 129, doi. 10.1007/s11102-016-0753-y
- By:
- Publication type:
- Article
Revised GH and cortisol cut-points for the glucagon stimulation test in the evaluation of GH and hypothalamic-pituitary-adrenal axes in adults: results from a prospective randomized multicenter study.
- Published in:
- Pituitary, 2016, v. 19, n. 3, p. 332, doi. 10.1007/s11102-016-0712-7
- By:
- Publication type:
- Article
Osilodrostat, a potent oral 11β-hydroxylase inhibitor: 22-week, prospective, Phase II study in Cushing's disease.
- Published in:
- Pituitary, 2016, v. 19, n. 2, p. 138, doi. 10.1007/s11102-015-0692-z
- By:
- Publication type:
- Article
Update on radiation therapy in patients with Cushing's disease.
- Published in:
- Pituitary, 2015, v. 18, n. 2, p. 263, doi. 10.1007/s11102-014-0615-4
- By:
- Publication type:
- Article
Investigation of impulsivity in patients on dopamine agonist therapy for hyperprolactinemia: a pilot study.
- Published in:
- Pituitary, 2014, v. 17, n. 2, p. 150, doi. 10.1007/s11102-013-0480-6
- By:
- Publication type:
- Article
Pathologic and clinical features of pituitary adenomas showing TSH immunoreactivity.
- Published in:
- Pituitary, 2013, v. 16, n. 3, p. 287, doi. 10.1007/s11102-012-0419-3
- By:
- Publication type:
- Article
12-Month effects of once-weekly sustained-release growth hormone treatment in adults with GH deficiency.
- Published in:
- Pituitary, 2013, v. 16, n. 3, p. 311, doi. 10.1007/s11102-012-0422-8
- By:
- Publication type:
- Article
Clinical characteristics, timing of peak responses and safety aspects of two dosing regimens of the glucagon stimulation test in evaluating growth hormone and cortisol secretion in adults.
- Published in:
- Pituitary, 2013, v. 16, n. 2, p. 220, doi. 10.1007/s11102-012-0407-7
- By:
- Publication type:
- Article
Medical management of Cushing's disease.
- Published in:
- Journal of Neuro-Oncology, 2014, v. 117, n. 3, p. 407, doi. 10.1007/s11060-013-1269-1
- By:
- Publication type:
- Article
Levoketoconazole treatment in endogenous Cushing's syndrome: extended evaluation of clinical, biochemical, and radiologic outcomes.
- Published in:
- European Journal of Endocrinology, 2022, v. 187, n. 6, p. 859, doi. 10.1530/EJE-22-0506
- By:
- Publication type:
- Article
Long-term outcomes of osilodrostat in Cushing's disease: LINC 3 study extension.
- Published in:
- European Journal of Endocrinology, 2022, v. 187, n. 4, p. 531, doi. 10.1530/EJE-22-0317
- By:
- Publication type:
- Article
Dose-exposure-IGF-I response of once-weekly somapacitan in adults with GH deficiency.
- Published in:
- European Journal of Endocrinology, 2022, v. 187, n. 1, p. 27, doi. 10.1530/EJE-21-1167
- By:
- Publication type:
- Article
All-cause mortality in patients with acromegaly treated with pegvisomant: an ACROSTUDY analysis.
- Published in:
- European Journal of Endocrinology, 2020, v. 182, n. 3, p. 285, doi. 10.1530/EJE-19-0794
- By:
- Publication type:
- Article
Use of late-night salivary cortisol to monitor response to medical treatment in Cushing's disease.
- Published in:
- European Journal of Endocrinology, 2020, v. 182, n. 2, p. 207, doi. 10.1530/EJE-19-0695
- By:
- Publication type:
- Article
Long-term treatment with pegvisomant: observations from 2090 acromegaly patients in ACROSTUDY.
- Published in:
- European Journal of Endocrinology, 2018, v. 179, n. 6, p. 419, doi. 10.1530/EJE-18-0616
- By:
- Publication type:
- Article
Increasing frequency of combination medical therapy in the treatment of acromegaly with the GH receptor antagonist pegvisomant.
- Published in:
- European Journal of Endocrinology, 2018, v. 178, n. 4, p. 321, doi. 10.1530/EJE-17-0996
- By:
- Publication type:
- Article
MOD-4023, a long-acting carboxy-terminal peptide-modified human growth hormone: results of a Phase 2 study in growth hormone-deficient adults.
- Published in:
- European Journal of Endocrinology, 2017, v. 176, n. 3, p. 283, doi. 10.1530/EJE-16-0748
- By:
- Publication type:
- Article
Effectiveness of first-line pegvisomant monotherapy in acromegaly: an ACROSTUDY analysis.
- Published in:
- European Journal of Endocrinology, 2017, v. 176, n. 2, p. 213, doi. 10.1530/EJE-16-0697
- By:
- Publication type:
- Article
Growth Hormone Research Society perspective on the development of long-acting growth hormone preparations.
- Published in:
- European Journal of Endocrinology, 2016, v. 174, n. 6, p. C1, doi. 10.1530/eje-16-0111
- By:
- Publication type:
- Article
Response to GH treatment in adult GH deficiency is predicted by gender, age, and IGF1 SDS but not by stimulated GH-peak.
- Published in:
- European Journal of Endocrinology, 2013, v. 168, n. 5, p. 733, doi. 10.1530/EJE-13-0005
- By:
- Publication type:
- Article
A longer interval without GH replacement and female gender are associated with lower bone mineral density in adults with childhood-onset GH deficiency: a KIMS database analysis.
- Published in:
- European Journal of Endocrinology, 2012, v. 167, n. 3, p. 343, doi. 10.1530/EJE-12-0070
- By:
- Publication type:
- Article
Comorbidity and cardiovascular risk factors in adult GH deficiency following treatment for Cushing's disease or non-functioning pituitary adenomas during childhood.
- Published in:
- European Journal of Endocrinology, 2012, v. 166, n. 4, p. 593, doi. 10.1530/EJE-11-0942
- By:
- Publication type:
- Article
Diagnosis, Genetics, and Therapy of Short Stature in Children: A Growth Hormone Research Society International Perspective.
- Published in:
- Hormone Research in Paediatrics, 2019, v. 92, n. 1, p. 1, doi. 10.1159/000502231
- By:
- Publication type:
- Article
Management of the clinically inapparent adrenal mass ("incidentaloma").
- Published in:
- 2003
- By:
- Publication type:
- journal article
Effects of Growth Hormone Administration on Inflammatory and Other Cardiovascular Risk Markers in Men with Growth Hormone Deficiency.
- Published in:
- Annals of Internal Medicine, 2000, v. 133, n. 2, p. 111, doi. 10.7326/0003-4819-133-2-200007180-00010
- By:
- Publication type:
- Article
Long-term mortality after transsphenoidal surgery for Cushing disease.
- Published in:
- 1999
- By:
- Publication type:
- journal article
Once-weekly Somapacitan is Effective and Well Tolerated in Adults with GH Deficiency: A Randomized Phase 3 Trial.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2020, v. 105, n. 4, p. e1358, doi. 10.1210/clinem/dgaa049
- By:
- Publication type:
- Article
Accuracy of Laboratory Tests for the Diagnosis of Cushing Syndrome.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Once-weekly Somapacitan is Effective and Well Tolerated in Adults with GH Deficiency: A Randomized Phase 3 Trial.
- Published in:
- 2020
- By:
- Publication type:
- journal article
A Consensus on the Diagnosis and Treatment of Acromegaly Comorbidities: An Update.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Effect of Growth Hormone Replacement on BMD in Adult-Onset Growth Hormone Deficiency.
- Published in:
- Journal of Bone & Mineral Research, 2007, v. 22, n. 5, p. 762, doi. 10.1359/JBMR.070205
- By:
- Publication type:
- Article
Age and bone mass in premenopausal women.
- Published in:
- Journal of Bone & Mineral Research, 1989, v. 4, n. 4, p. 533, doi. 10.1002/jbmr.5650040412
- By:
- Publication type:
- Article
Potential Cardiac Valve Effects of Dopamine Agonists in Hyperprolactinemia.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2010, v. 95, n. 3, p. 1025, doi. 10.1210/jc.2009-2095
- By:
- Publication type:
- Article
Delayed remission after transsphenoidal surgery in patients with Cushing's disease.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Growth hormone deficiency after treatment of acromegaly: a randomized, placebo-controlled study of growth hormone replacement.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Concomitant medication use can confound interpretation of the combined dexamethasone-corticotropin releasing hormone test in Cushing's syndrome.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Is Lack of Recombinant Growth Hormone (GH)-Releasing Hormone in the United States a Setback or Time to Consider Glucagon Testing for Adult GH Deficiency?
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2009, v. 94, n. 8, p. 2702, doi. 10.1210/jc.2009-0299
- By:
- Publication type:
- Article